Abbott Laboratories' (ABT) AbbVie spin-off is worth more than Abbott ahead of the official split...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

Abbott Laboratories' (ABT) AbbVie spin-off is worth more than Abbott ahead of the official split of the company in January. "When issued" trading in the two entities began yesterday in the secondary market, with the new Abbott valued at $47.9B and AbbVie $55.3B. The market cap of the combined Abbott is $103.27B.